• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非洲爪蟾促肾上腺皮质激素释放因子受体1配体选择性结构域的定位:对配体结合位点的启示

Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.

作者信息

Dautzenberg F M, Wille S, Lohmann R, Spiess J

机构信息

Max-Planck Institute for Experimental Medicine, Department of Molecular Neuroendocrinology, Hermann-Rein-Strasse 3, 37075 Goettingen, Germany.

出版信息

Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4941-6. doi: 10.1073/pnas.95.9.4941.

DOI:10.1073/pnas.95.9.4941
PMID:9560207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC20192/
Abstract

The nonselective human corticotropin-releasing factor receptor 1 (hCRF-R1) and the ligand-selective Xenopus CRF-R1 (xCRF-R1) were compared. To understand the interactions of sauvagine and ovine CRF, both high-affinity ligands for hCRF-R1 but surprisingly weak ligands for xCRF-R1, chimeric receptors of hCRF-R1 and xCRF-R1 followed by double or multiple point mutations were constructed. Binding studies and cAMP assays demonstrated that the N-terminal domain exhibited the complete ligand selectivity of xCRF-R1. The important region was mapped between amino acids 70 and 89; replacement of amino acids Arg76, Asn81, Gly83, Leu88, and Ala89 in hCRF-R1 with the corresponding amino acids of xCRF-R1 (Gln76, Gly81, Val83, His88, and Leu89) resulted in a receptor that had approximately 30-fold higher affinity for human/rat CRF than for sauvagine. Mutagenesis of these amino acids in xCRF-R1 to the human sequence completely abolished the ligand selectivity of xCRF-R1. Mutagenesis of amino acids 88 and 89 in hCRF-R1 or xCRF-R1 had only a minor (approximately 2.5-fold) effect on the ligand selectivity of the mutant receptor. Substitution of Arg76, Asn81, and Gly83 in hCRF-R1 with the corresponding sequence of xCRF-R1 (Gln76, Gly81, and Val83) resulted in a receptor with approximately 11-fold higher affinity for human/rat CRF compared with ovine CRF or sauvagine. When only two of these three amino acids were mutated, no effect on the ligand selectivity was observed. On the basis of these data, it is suggested that amino acids 70-89 of CRF-R1 are important for the ligand binding site.

摘要

对非选择性的人类促肾上腺皮质激素释放因子受体1(hCRF-R1)和配体选择性的非洲爪蟾促肾上腺皮质激素释放因子受体1(xCRF-R1)进行了比较。为了解铃蟾肽和绵羊促肾上腺皮质激素释放因子(CRF)的相互作用,二者都是hCRF-R1的高亲和力配体,但令人惊讶的是对xCRF-R1而言却是弱配体,构建了hCRF-R1和xCRF-R1的嵌合受体,随后进行双点或多点突变。结合研究和环磷酸腺苷(cAMP)分析表明,N端结构域表现出xCRF-R1完整的配体选择性。重要区域定位在氨基酸70至89之间;将hCRF-R1中的氨基酸精氨酸76、天冬酰胺81、甘氨酸83、亮氨酸88和丙氨酸89替换为xCRF-R1的相应氨基酸(谷氨酰胺76、甘氨酸81、缬氨酸83、组氨酸88和亮氨酸89),得到一种对人/大鼠CRF的亲和力比对铃蟾肽高约30倍的受体。将xCRF-R1中的这些氨基酸突变为人类序列完全消除了xCRF-R1的配体选择性。对hCRF-R1或xCRF-R1中的氨基酸88和89进行诱变,对突变受体的配体选择性只有轻微(约2.5倍)影响。将hCRF-R1中的精氨酸76、天冬酰胺81和甘氨酸83替换为xCRF-R1的相应序列(谷氨酰胺76、甘氨酸81和缬氨酸83),得到一种对人/大鼠CRF的亲和力比对绵羊CRF或铃蟾肽高约11倍的受体。当这三个氨基酸中只有两个发生突变时,未观察到对配体选择性有影响。基于这些数据,提示促肾上腺皮质激素释放因子受体1的氨基酸70 - 89对配体结合位点很重要。

相似文献

1
Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.非洲爪蟾促肾上腺皮质激素释放因子受体1配体选择性结构域的定位:对配体结合位点的启示
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4941-6. doi: 10.1073/pnas.95.9.4941.
2
Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding.促肾上腺皮质激素释放因子受体1 N端结构域中作为高亲和力配体结合重要决定因素的氨基酸的鉴定。
J Neurochem. 1999 Jan;72(1):388-95. doi: 10.1046/j.1471-4159.1999.0720388.x.
3
Five amino acids of the Xenopus laevis CRF (corticotropin-releasing factor) type 2 receptor mediate differential binding of CRF ligands in comparison with its human counterpart.非洲爪蟾促肾上腺皮质激素释放因子(CRF)2型受体的五个氨基酸与其人类对应物相比,介导了CRF配体的差异结合。
Mol Pharmacol. 2002 May;61(5):1132-9. doi: 10.1124/mol.61.5.1132.
4
The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile.促肾上腺皮质激素释放因子1型和2型受体的配体选择性结构域位于不同的细胞外结构域:具有新型配体选择性特征的嵌合受体的产生。
J Neurochem. 1999 Aug;73(2):821-9. doi: 10.1046/j.1471-4159.1999.0730821.x.
5
Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.人类和两栖类促肾上腺皮质激素释放因子1型(CRF(1))受体的结合差异:介导高亲和力阿斯特辛结合和功能拮抗作用的氨基酸鉴定
Regul Pept. 2004 May 15;118(3):165-73. doi: 10.1016/j.regpep.2003.12.012.
6
Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences.两栖动物与人类促肾上腺皮质激素释放因子1型和2型受体的不同结合模式:进化差异的证据
J Pharmacol Exp Ther. 2001 Jan;296(1):113-20.
7
125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors.125I-抗 sauvagine-30:一种用于鉴定促肾上腺皮质激素释放因子 2 型受体的新型特异性高亲和力放射性配体。
Neuropharmacology. 2001;40(1):114-22. doi: 10.1016/s0028-3908(00)00105-2.
8
Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor.
J Neurochem. 1997 Oct;69(4):1640-9. doi: 10.1046/j.1471-4159.1997.69041640.x.
9
Evidence for the abundant expression of arginine 185 containing human CRF(2alpha) receptors and the role of position 185 for receptor-ligand selectivity.含精氨酸185的人促肾上腺皮质激素释放因子(CRF)(2α)受体大量表达的证据以及185位对受体-配体选择性的作用。
Neuropharmacology. 2000 Jun 8;39(8):1368-76. doi: 10.1016/s0028-3908(00)00044-7.
10
Ligand requirements of the human corticotropin-releasing factor-binding protein.人促肾上腺皮质激素释放因子结合蛋白的配体需求
Endocrinology. 1995 Mar;136(3):1097-102. doi: 10.1210/endo.136.3.7867564.

引用本文的文献

1
Regulatory Pathways of Monoamine Oxidase A during Social Stress.社会应激期间单胺氧化酶A的调控途径
Front Neurosci. 2017 Oct 31;11:604. doi: 10.3389/fnins.2017.00604. eCollection 2017.
2
NMR structure of the first extracellular domain of corticotropin-releasing factor receptor 1 (ECD1-CRF-R1) complexed with a high affinity agonist.促肾上腺皮质激素释放因子受体 1(ECD1-CRF-R1)的第一细胞外结构域与高亲和力激动剂复合物的 NMR 结构。
J Biol Chem. 2010 Dec 3;285(49):38580-9. doi: 10.1074/jbc.M110.121897. Epub 2010 Sep 15.
3
Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1.促肾上腺皮质激素释放因子与其G蛋白偶联受体CRFR1的分子识别
J Biol Chem. 2008 Nov 21;283(47):32900-12. doi: 10.1074/jbc.M805749200. Epub 2008 Sep 17.
4
Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand.与肽配体结合的B1型G蛋白偶联受体N端结构域的结构
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):4858-63. doi: 10.1073/pnas.0700682104. Epub 2007 Mar 12.
5
Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.中枢神经系统中促肾上腺皮质激素释放因子(CRF)受体信号传导:新的分子靶点。
CNS Neurol Disord Drug Targets. 2006 Aug;5(4):453-79. doi: 10.2174/187152706777950684.
6
Corticotropin releasing factor 2 receptor agonists reduce the denervation-induced loss of rat skeletal muscle mass and force and increase non-atrophying skeletal muscle mass and force.促肾上腺皮质激素释放因子2受体激动剂可减少去神经支配诱导的大鼠骨骼肌质量和力量损失,并增加非萎缩性骨骼肌质量和力量。
J Muscle Res Cell Motil. 2004;25(7):539-47. doi: 10.1007/s10974-004-4088-3. Epub 2005 Feb 9.
7
Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1.大鼠促肾上腺皮质激素释放因子受体1 N端结构域的功能与蛋白质化学特性
Protein Sci. 2001 Oct;10(10):2050-62. doi: 10.1110/ps.12101.
8
Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2.促肾上腺皮质激素释放因子(CRF)与应激对学习和焦虑的调节作用:CRF受体1和2的不同作用
J Neurosci. 1999 Jun 15;19(12):5016-25. doi: 10.1523/JNEUROSCI.19-12-05016.1999.

本文引用的文献

1
The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.促肾上腺皮质激素释放因子受体1的第一个细胞外结构域包含尿皮质素和抗压素的主要结合决定簇。
Endocrinology. 1998 Feb;139(2):566-70. doi: 10.1210/endo.139.2.5757.
2
Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor.
J Neurochem. 1997 Oct;69(4):1640-9. doi: 10.1046/j.1471-4159.1997.69041640.x.
3
Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.血管活性肠肽与垂体腺苷酸环化酶激活肽受体嵌合体揭示了决定血管活性肠肽结合和激活特异性的结构域。
Mol Pharmacol. 1997 Jul;52(1):128-35. doi: 10.1124/mol.52.1.128.
4
Localization of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeric receptor approach.
Mol Endocrinol. 1997 Jun;11(7):980-5. doi: 10.1210/mend.11.7.9946.
5
Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling.用于特异性受体标记的促肾上腺皮质激素释放因子光活化类似物的合成与表征
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10609-13. doi: 10.1073/pnas.93.20.10609.
6
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors.
Peptides. 1996;17(5):825-9. doi: 10.1016/0196-9781(96)00107-6.
7
Mutational analysis and molecular modeling of the nonapeptide hormone binding domains of the [Arg8]vasotocin receptor.[精氨酸8] 血管紧张素受体的九肽激素结合域的突变分析与分子建模
Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6907-12. doi: 10.1073/pnas.93.14.6907.
8
Cloning and characterization of human urocortin.人尿皮质素的克隆与特性分析
Endocrinology. 1996 May;137(5):2167-70. doi: 10.1210/endo.137.5.8612563.
9
Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid.
Endocrinology. 1996 Jan;137(1):72-7. doi: 10.1210/endo.137.1.8536644.
10
Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I.
Endocrinology. 1996 Jan;137(1):192-7. doi: 10.1210/endo.137.1.8536612.